Related Experiment Video
Updated: Aug 26, 2025
10:39
3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
18.3K
Management of chronic migraine
Alexandra Hovaguimian1, Julie Roth2
1Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA ahovagui@bidmc.harvard.edu.
BMJ (Clinical Research Ed.)
|October 10, 2022
Summary
New treatments for chronic migraine, including CGRP antagonists and neuromodulatory devices, offer hope for this disabling neurologic disorder. This review covers diagnosis, risk factors, and evidence-based treatments for improved patient care.
Area of Science:
- Neurology
- Public Health
Background:
- Chronic migraine is a debilitating neurologic disorder with significant global disability and economic impact.
- Recent years have seen rapid advancements in therapeutic options for chronic migraine management.
Purpose of the Study:
- To provide a comprehensive overview of chronic migraine, encompassing epidemiology, diagnosis, and risk factors.
- To review current evidence-based drug and non-drug treatments, patient-centered care principles, and management in special populations.
- To discuss emerging research and future directions in chronic migraine treatment.
Main Methods:
- Systematic review of current literature on chronic migraine.
- Analysis of diagnostic criteria, risk factors, and epidemiological data.
- Evaluation of international guidelines and evidence for various therapeutic interventions.
Main Results:
- New treatments like calcitonin gene-related peptide (CGRP) antagonists and neuromodulatory devices have expanded therapeutic options.
- A wide range of drug and non-drug treatments, including behavioral therapies and lifestyle modifications, are available.
- Management strategies must consider comorbidities, patient-centered care, cost, and availability.
Conclusions:
- Effective management of chronic migraine requires a comprehensive approach, integrating pharmacological and non-pharmacological strategies.
- Patient-centered care, considering individual needs and comorbidities, is crucial for optimizing outcomes.
- Ongoing research and the development of novel therapies hold promise for improving the lives of individuals with chronic migraine.
Related Concept Videos
01:29Chronic Pancreatitis II: Collaborative Care
123
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
123
01:19Management of Insomnia
312
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
312
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.7K
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
4.2K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
4.2K
01:26Angina IV: Management
16
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
16
01:24Cystic Fibrosis: Management
213
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
213